These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Bulimia, menstruation, and PMS: treatment implications. Price WA; DiMarzio LR Am J Psychiatry; 1988 Sep; 145(9):1178-9. PubMed ID: 3414867 [No Abstract] [Full Text] [Related]
65. A double-blind placebo-controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome. Maddocks S; Hahn P; Moller F; Reid RL Am J Obstet Gynecol; 1986 Mar; 154(3):573-81. PubMed ID: 3513587 [TBL] [Abstract][Full Text] [Related]
66. No effect of vitamin B-6 against premenstrual tension. A controlled clinical study. Hagen I; Nesheim BI; Tuntland T Acta Obstet Gynecol Scand; 1985; 64(8):667-70. PubMed ID: 3914180 [TBL] [Abstract][Full Text] [Related]
67. Premenstrual syndrome. A general practice view. McMurchie M; Hindmarsh E Aust Fam Physician; 1989 Feb; 18(2):105, 108-9. PubMed ID: 2705942 [TBL] [Abstract][Full Text] [Related]
68. A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria. Steinberg S; Annable L; Young SN; Liyanage N Biol Psychiatry; 1999 Feb; 45(3):313-20. PubMed ID: 10023508 [TBL] [Abstract][Full Text] [Related]
70. Melatonin and the reduction or alleviation of stress. Kirby AW; Clayton M; Rivera P; Comperatore CA J Pineal Res; 1999 Sep; 27(2):78-85. PubMed ID: 10496143 [TBL] [Abstract][Full Text] [Related]
71. Fluctuations in symptoms and moods during the menstrual cycle. Moos RH; Kopell BS; Melges FT; Yalom ID; Lunde DT; Clayton RB; Hamburg DA J Psychosom Res; 1969 Mar; 13(1):37-44. PubMed ID: 5813369 [No Abstract] [Full Text] [Related]
72. Puerperal and premenopausal depression. Med J Aust; 1972 Mar; 1(11):504. PubMed ID: 5066529 [No Abstract] [Full Text] [Related]
75. Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study. Wang M; Hammarbäck S; Lindhe BA; Bäckström T Acta Obstet Gynecol Scand; 1995 Nov; 74(10):803-8. PubMed ID: 8533564 [TBL] [Abstract][Full Text] [Related]
76. Sex differences in the hypothalamic-pituitary-adrenal axis: An obstacle to antidepressant drug development? Kokras N; Hodes GE; Bangasser DA; Dalla C Br J Pharmacol; 2019 Nov; 176(21):4090-4106. PubMed ID: 31093959 [TBL] [Abstract][Full Text] [Related]
77. Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder? Halbreich U; O'Brien PM; Eriksson E; Bäckström T; Yonkers KA; Freeman EW CNS Drugs; 2006; 20(7):523-47. PubMed ID: 16800714 [TBL] [Abstract][Full Text] [Related]
78. The role of hormones and hormonal treatments in premenstrual syndrome. Bäckström T; Andreen L; Birzniece V; Björn I; Johansson IM; Nordenstam-Haghjo M; Nyberg S; Sundström-Poromaa I; Wahlström G; Wang M; Zhu D CNS Drugs; 2003; 17(5):325-42. PubMed ID: 12665391 [TBL] [Abstract][Full Text] [Related]
79. Premenstrual syndrome and spironolactone. Burnet RB; Radden HS; Easterbrook EG; McKinnon RA Aust N Z J Obstet Gynaecol; 1991 Nov; 31(4):366-8. PubMed ID: 1799355 [TBL] [Abstract][Full Text] [Related]
80. A double-blind, placebo-controlled evaluation of spironolactone in the premenstrual syndrome. Vellacott ID; Shroff NE; Pearce MY; Stratford ME; Akbar FA Curr Med Res Opin; 1987; 10(7):450-6. PubMed ID: 3621990 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]